Peter Bonutti

Company: Realeve

Job title: Chief Executive Officer

Seminars:

11.30 Realeve: Enabling CNS Drug Delivery through On-Demand Control of the BBB 11:30 am

Realeve has developed the Pulsante Neurostimulator, an implantable device which can control the permeability of the BBB by relaxing and tightening tight junction proteins through on-demand stimulation of the SPG, allowing delivery of large molecule frugs including monoclonal antibodies and stem cells increasing efficacy while reducing dosing and decreasing the risk of complications Pulsante has…Read more

day: Day One Track 2 AM